Search Results - "Ready, Neal"

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer

Authors: Shah, Chirag Ready, Neal Perry, Michel et al.

Source: Lung Cancer (01695002). Jul2007, Vol. 57 Issue 1, p84-88. 5p.

Targeting MET Amplification with Crizotinib in a Case of Sinonasal Undifferentiated Carcinoma.

Authors: Robinson, Hannah Green, Michelle Radkar, Gauri et al.

Source: Cancer Investigation. Mar2021, Vol. 39 Issue 3, p235-239. 5p.

Role of induction chemotherapy in sinonasal malignancies: a systematic review.

Authors: Khoury, Tawfiq Jang, David Carrau, Ricardo et al.

Source: International Forum of Allergy & Rhinology. Feb2019, Vol. 9 Issue 2, p212-219. 8p.

Phase II Study of Dasatinib in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer.

Authors: Kelley, Michael J. Jha, Gautam Shoemaker, Debra et al.

Source: Cancer Investigation. 2017, Vol. 35 Issue 1, p32-35. 4p.

Patient-Reported Distress and Clinical Outcomes with Immuno-Oncology Agents in Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Real-World Retrospective Cohort Study.

Authors: Bodd, Monica H. Locke, Susan C. Wolf, Steve P. et al.

Source: Lung Cancer (01695002). Jan2023, Vol. 175, p17-26. 10p.

Tumor Acquisition for Biomarker Research in Lung Cancer.

Authors: Stevenson, Marvaretta Christensen, Jared Shoemaker, Debra et al.

Source: Cancer Investigation. Jul2014, Vol. 32 Issue 6, p291-298. 8p.

Diabetes mellitus: A significant co-morbidity in the setting of lung cancer?

Authors: Washington, Iman Chino, Junzo P. Marks, Lawrence B. et al.

Source: Thoracic Cancer. May2013, Vol. 4 Issue 2, p123-130. 8p.

Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy.

Authors: Zandberg, Dan P. Algazi, Alain P. Jimeno, Antonio et al.

Source: European Journal of Cancer. Jan2019, Vol. 107, p142-152. 11p.

Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non–small-cell lung cancer.

Authors: Liu, Stephen V. Camidge, D. Ross Gettinger, Scott N. et al.

Source: European Journal of Cancer. Sep2018, Vol. 101, p114-122. 9p.

Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study.

Authors: Hellmann, Matthew D Rizvi, Naiyer A Goldman, Jonathan W et al.

Source: Lancet Oncology. Jan2017, Vol. 18 Issue 1, p31-41. 11p.

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.

Authors: Rudin, Charles M Pietanza, M Catherine Bauer, Todd M et al.

Source: Lancet Oncology. Jan2017, Vol. 18 Issue 1, p42-51. 10p.

Phase 1 Dose Escalation Study of Accelerated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Lung Cancer.

Authors: Kelsey, Chris R. Das, Shiva Gu, Lin et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Dec2015, Vol. 93 Issue 5, p997-1004. 8p.

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.

Authors: Brahmer, Julie Reckamp, Karen L. Baas, Paul et al.

Source: New England Journal of Medicine. 7/9/2015, Vol. 373 Issue 2, p123-135. 13p.

Smoking history predicts for increased risk of second primary lung cancer: A comprehensive analysis.

Authors: Boyle, John M. Tandberg, Daniel J. Chino, Junzo P. et al.

Source: Cancer (0008543X). Feb2015, Vol. 121 Issue 4, p598-604. 7p.

A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors.

Authors: Uronis, Hope Jia, Jingquan Bendell, Johanna et al.

Source: Cancer Chemotherapy & Pharmacology. Feb2015, Vol. 75 Issue 2, p343-352. 10p.

A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors.

Authors: Vlahovic, Gordana Meadows, Kellen Uronis, Hope et al.

Source: Cancer Chemotherapy & Pharmacology. Jul2012, Vol. 70 Issue 1, p95-102. 8p.

Local Failure in Resected N1 Lung Cancer: Implications for Adjuvant Therapy

Authors: Higgins, Kristin A. Chino, Junzo P. Berry, Mark et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Jun2012, Vol. 83 Issue 2, p727-733. 7p.